VIDO pursuing more vaccines to provide tools for safer food
 |
| Dr. Andrew Potter |
By Michael Robin
As food safety gains more attention in the
public eye, a research institution on campus works quietly to develop tools to
keep the food supply free of lethal microbes.
The Veterinary Infectious Disease
Organization (VIDO) is a not-for-profit institute wholly owned by
the
University of Saskatchewan. It is a global leader in food animal and poultry
vaccine research for the control of infectious diseases.
According to Dr. Andrew Potter, Associate
Director for Science, vaccines are not only critical for the health of food
animals, they are essential to produce products safe for us to eat.
One example is ‘E. coli O157:H7’ — the bug responsible for wreaking havoc with
the water supply in Walkerton, Ont., sickening and killing the townspeople.
This microbe also causes that bane of backyard barbeques, ‘hamburger disease’.
“Why aren’t we vaccinating animals to
prevent that?” Potter asks. “It doesn’t cause any disease in animals, but the
principle is still there, and in fact there are a number of vaccines under
development, including ones at VIDO.”
In fact, a collaborative effort between
Potter and Dr. Brett Finlay at the University of British Columbia may have
yielded one of the first vaccines to control E. coli O157:H7 in cattle.
“We’ve been able to demonstrate that by
using technology developed by Finlay, it’s possible to substantially reduce the
levels of (the bacteria) in vaccinated cattle,” Potter says. Field trials of
the vaccine are slated to begin in September, 2001.
Hoof and mouth disease is also an area
where VIDO work may play an indirect role, in providing more doses of vaccine
than current manufacturing methods.
Currently, there is no good way to contain
hoof and mouth once it takes hold. The response has been “scorched earth”, as
seen with the recent outbreak in the United Kingdom. All animals infected or
suspected of being infected are slaughtered, burned and buried.
Another strategy is to vaccinate all
animals, but vaccines cause the same immune response as the disease. Tests
can’t tell the difference between an infected animal and a vaccinated one, and
they cannot be exported.
Potter explains that one strategy being
considered in the U.K. is “perimeter vaccination”, that is, destroy all
infected animals, then vaccinate those within a given area around the infection
site.
In either case, manufacturing enough doses
is a challenge.
“There’s simply not enough of it.,” Potter
says. “If there was an outbreak in Europe, in North America, there wouldn’t be
enough vaccine to vaccinate the animals.”
VIDO is collaborating with Saskatoon-based
PharmaDerm to increase efficacy of
vaccines and multiply dose manufacture. While this technology hasn’t been
applied to foot and mouth, it has potential for wide application in animal and
human health.
“What we were able to show at VIDO is, we
took a vaccine that was in use and were able to reduce the dose 10 times,”
Potter says.
VIDO is also working on delivery systems
that would make needles obsolete. According to Potter, needle technology is as
old as Pasteur: you find something that induces an immune response, mix it with
an oil, and inject it. Eliminating needles would be a boon to animals, farmers
and exporters.
Potter explains that despite the best
efforts of animal husbandry, needles occasionally break off inside the animal.
One exporter was warned by a Japanese customer that a needle had been found in
their meat, and that if it happened again, they would take their business
elsewhere. A needle showed up in a later shipment, and the exporter hasn’t sold
into the Japanese market since.
VIDO’s approach is to develop oral, nasal
and even suppository vaccines to induce an
immune response right where diseases attack — at the mucous membranes.
Ultimately, vaccination is about healthier
animals, and, according to Potter, that means safer food. “I would rather, as a consumer, eat food
from a vaccinated animal, than one that had been exposed and had diseases
caused by any number of viruses or bacteria,” he says.
For more information, contact
communications.office@usask.ca
Articles Index |
|
Home · About Us · Issue dates · Submissions · AD Information · Back Issues · Headline Index · OCN Policies
|